CN113881731A - Synthetic method of L-tagatose - Google Patents

Synthetic method of L-tagatose Download PDF

Info

Publication number
CN113881731A
CN113881731A CN202111090827.2A CN202111090827A CN113881731A CN 113881731 A CN113881731 A CN 113881731A CN 202111090827 A CN202111090827 A CN 202111090827A CN 113881731 A CN113881731 A CN 113881731A
Authority
CN
China
Prior art keywords
ala
gly
leu
val
tagatose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111090827.2A
Other languages
Chinese (zh)
Inventor
张新帅
朱闰婕
李咏欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China Normal University
Original Assignee
South China Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China Normal University filed Critical South China Normal University
Priority to CN202111090827.2A priority Critical patent/CN113881731A/en
Publication of CN113881731A publication Critical patent/CN113881731A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/02Monosaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01021Aldehyde reductase (1.1.1.21), i.e. aldose-reductase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a synthesis method of L-tagatose, which comprises the steps of converting galactitol into L-tagatose-6-phosphate under the combined action of oxidase GatDH and kinase TgK, and then dephosphorizing by using phosphohydrolase APase to obtain L-tagatose; or D-galactose is reduced to galactitol by reductase aldR, and then the galactitol is converted to L-tagatose by oxidase GatDH. The invention adopts cheap bulk D-galactose or galactitol as raw material, and obtains expensive L-tagatose by continuous conversion of a plurality of enzymes. The preparation scheme has the advantages of various industrial applications, cheap used raw materials, short preparation route, simple reaction conditions and low waste discharge; the characteristics well meet the basic requirements of the current green industrial production.

Description

Synthetic method of L-tagatose
Technical Field
The invention belongs to the field of biological enzyme synthesis, and particularly relates to a synthetic method of L-tagatose.
Background
L-tagatose (L-tagatose) is a rare sugar existing in nature, is a low-calorie functional sweetener, and is particularly an additive of various detergents, cosmetics and medicines. Meanwhile, L-tagatose is also a raw material for synthesizing a galactosidase inhibitor (L-deoxygalctojirimycin) and has a special effect on the chemotherapy of cancers. However, the high price limits the promotion (the price of L-tagatose is 20,000/g in Carbosynth, a sugar selling company known internationally).
There are several methods for preparing L-tagatose reported so far, but all have some defects, which make it impossible to produce and apply L-tagatose on a large scale at a low cost.
In a chemical preparation route, the synthesis of L-tagatose needs to undergo multi-step hydroxyl protection and deprotection, which not only leads to overlong preparation route and low overall yield, but also greatly troubles the purification of later-stage products due to chiral racemization problem in the preparation process.
The L-tagatose produced by fermentation has low product concentration and purity, so that the purification cost of the final product is too high, and the effective large-scale production cannot be realized.
Disclosure of Invention
The invention aims to provide a method for synthesizing L-tagatose, which realizes direct conversion from cheap galactitol or D-galactose to L-tagatose through multi-stage enzyme-linked catalysis, has short preparation route, simple reaction condition and high conversion rate, and therefore has remarkable advantages in production cost and environmental protection.
The purpose of the invention is realized by the following technical scheme:
the synthesis method of the L-tagatose comprises the following steps:
(1) mixing galactitol, adenosine disodium triphosphate ATP, nicotinamide adenine dinucleotide monosodium salt, magnesium salt and potassium salt, adjusting the pH value of a system to be 7.0-8.5 (the pH value range is maintained in the reaction process), adding galactitol dehydrogenase (GatDH) and ketohexokinase (TgK), reacting for 4-10 hours at room temperature, then adding barium oxalate, stirring for dissolving, adding absolute ethyl alcohol, mixing and precipitating L-tagatose-6-phosphoric acid, and centrifuging to collect white solid precipitate; re-dissolving white solid precipitate to remove Ba2+Ionizing and further purifying to obtain L-tagatose-6-phosphoric acid;
(2) taking L-tagatose-6-phosphoric acid, adding phosphohydrolase (APase), and reacting at 20-30 ℃ for 2-5 hours to generate L-tagatose;
preferably, the step (1) can also be simultaneously added with Lactate Dehydrogenase (LDH), acetate kinase (AcK),Sodium pyruvate, and a solution of acetic acid phosphate to convert NADH to NAD using Lactate Dehydrogenase (LDH)+Acetate kinase (AcK) regenerates ADP to ATP, thereby reducing the amount of coenzyme and ATP used;
wherein the enzyme activity ratio of galactitol dehydrogenase (GatDH), ketohexokinase (TgK), Lactate Dehydrogenase (LDH) and acetate kinase (AcK) is 2 (3-5) to (1-3) to (3-8), preferably 2:4:1.5: 5.
Wherein the molar ratio of the galactitol to the sodium pyruvate is (0.90-1.15) 1; other raw materials are either enzyme substrates or salts required for enzyme activity, and the required dosage is less;
re-dissolving the white solid precipitate in the step (1) to remove Ba2+Dissolving the white solid precipitate in Tris buffer solution with pH value of 1.0, and adding anhydrous sodium sulfate and Ba2+Carrying out ion reaction to generate white barium sulfate precipitate, and filtering to remove the white barium sulfate precipitate;
further purification as described in step (1) is to remove Ba2+Adjusting pH of the supernatant to neutral, loading onto anion resin exchange column, eluting with ammonia bicarbonate water solution (0-1N) with gradient concentration, and separating to obtain L-tagatose-6-phosphoric acid.
The synthesis method of the L-tagatose comprises the following steps:
mixing D-galactose and reduced nicotinamide adenine dinucleotide disodium salt (NADH), adjusting the pH value of the solution to 6.5-8.5, adding D-galactose reductase (aldR) and galactitol dehydrogenase (GatDH, EC 1.1.1.406), and reacting at 20-27 ℃ for 4-10 hours to generate L-tagatose;
the D-galactose reductase (aldR) used by the invention, the wild type (Unit ID: A0A2S9ZVX5, EC 1.1.1.21) of which is from Rhodotorula toruloides, and the wild type coenzyme is NADPH, can effectively utilize NADH after the site-specific modification of the invention, and the mutation sites are as follows: K247W, S248L and R253M, wherein the modified amino acid sequence is shown in SEQ ID No. 6.
The activity ratio of the D-galactose reductase to the galactitol dehydrogenase is 1 (2.5-4.0).
In the two routes, after the reaction (for route one, the reaction in the step (2)) is finished, removing or recovering the enzyme, removing impurities from the reaction solution by anion exchange resin, and then desalting, concentrating and crystallizing to obtain the L-tagatose;
the desalting can be carried out by prior art methods such as G25 size exclusion column desalting or osmotic membrane desalting.
The enzyme is liquid enzyme or immobilized enzyme;
if liquid enzyme is adopted, the pH value of a reaction system is adjusted to be strong acid after reaction, protein is precipitated, and the protein is removed by centrifugation;
if immobilized enzyme is adopted, the reaction is filtered and recycled.
Preferably, the reactant is added into tris (hydroxymethyl) aminomethane hydrochloride (Tris.HCl), hydroxyethyl piperazine ethanesulfonic acid (Hepes) buffer solution or 3-morpholine propanesulfonic acid (MOPS) buffer solution for reaction; phosphate buffer systems are not suitable for use herein and result in low reactivity of the enzyme.
The immobilized enzyme is prepared by the following steps:
mixing the required enzymes or dissolving the required enzymes in 50mM potassium phosphate solution with pH 8.0, then adding 40mM phenoxyacetic acid and LX-1000EP epoxy resin to the buffer solution, stirring for 5 hours at room temperature, filtering out the immobilized enzyme, finally washing with clear water and 25mM phosphate buffer solution with pH 8.0 for three times respectively, and drying at low temperature for later use;
the immobilized aldR and GatDH mixed enzyme has 70-85% of the activity of the corresponding liquid enzyme. The immobilized Apase activity is 85-94% of that of the corresponding liquid enzyme.
Compared with the prior art, the invention has the following advantages and effects:
1. the invention adopts cheap and large amount of D-galactose or galactitol in the market as raw material, and obtains expensive L-tagatose by continuous conversion of a plurality of enzymes. The preparation scheme has the advantages of various industrial applications, cheap used raw materials, short preparation route, simple reaction conditions and low waste discharge; the characteristics well meet the basic requirements of the current green industrial production.
2. One route of the invention takes the cheap galactitol (1200/kg, aladdin reagent net) as a raw material, converts the galactitol dehydrogenase (GatDH, EC 1.1.1.406) in the rhodobacter sphaeroides and the ketohexokinase (TgK, EC 2.7.1.209) of the propionibacterium into the L-tagatose-6-phosphate with high yield, and then dephosphorylates under the action of phosphohydrolase (APase, EC 3.1.3.1) to obtain the L-tagatose; coenzyme NAD + regeneration enzyme (LDH, EC 1.1.1.27) and ATP regeneration enzyme (AcK, EC 2.7.2.1) are introduced in the reaction, so that the dosage of the coenzyme can be obviously reduced.
3. In another preparation route of the invention, D-galactose is taken as a raw material, D-galactose reductase (aldR) and galactitol dehydrogenase (GatDH, EC 1.1.1.406) in rhodobacter sphaeroides are coupled to directly convert D-galactose into L-tagatose, and the reaction adopts D-galactose reductase (aldR, EC 1.1.1.21) and utilizes NADH as coenzyme to generate NAD+(the coenzyme for the aldR native enzyme is NADPH), while the dehydrogenase GatDH converts NAD+Reducing the coenzyme into NADH, thereby effectively realizing the recycling of the coenzyme in the two-step reaction, and only adding catalytic amount of the coenzyme; the scheme simplifies the process and effectively improves the conversion rate of two steps.
Drawings
FIG. 1 is an HPLC chromatogram of L-tagatose.
FIG. 2 is a schematic representation of L-tagatose1H-NMR spectrum.
FIG. 3 shows the results of SDS-PAGE gel detection of the enzyme.
Detailed Description
The present invention will be described in further detail with reference to examples and drawings, but the present invention is not limited thereto.
The information on the enzymes to which the present invention relates is as follows:
galactitol dehydrogenase (GatDH): derived from Rhodococcus sphaeroides (PDB:2WDZ, EC 1.1.1.406), the amino acid and DNA sequences of which are shown in SEQ ID No.1 and NO.7, respectively;
lactate Dehydrogenase (LDH): derived from Rhizobium radiobacter (Uniprot ID: A9CFS1, EC 1.1.1.27), and the amino acid and DNA sequences thereof are shown in SEQ ID No.2 and NO.8, respectively;
ketohexokinase (TgK): derived from Propionibacterium (Propionibacterium namnense) (Unit ID: F9NVE9, EC 2.7.1.209), the amino acid and DNA sequences of which are shown in SEQ ID No.3 and NO.9, respectively;
acetate kinase (AcK): is derived from Escherichia coli (E.coli) (Unit ID: P0A6A3, EC 2.7.2.1), and the amino acid and DNA sequences thereof are respectively shown in SEQ. ID. NO.4 and NO. 10;
alkaline phosphohydrolase (APase): is derived from Pseudomonas aeruginosa (Uniprot ID: P35482, EC 3.1.3.1), and has amino acid and DNA sequences shown in SEQ ID No.5 and NO.11, respectively.
Example 1: preparation of aqueous solution of acetic acid phosphoric acid
65ml of phosphoric acid (85%, 2.0mol) are dissolved in 500ml of ethyl acetate and then cooled to 0 ℃; to this solution 190ml of cooled acetic anhydride (2.0mol) was slowly added dropwise. The mixture was stirred at 0 ℃ for 8 hours and poured into a3 l reaction flask containing 500ml of water, 250 g of ice and 64 g of sodium bicarbonate. The mixture was continued to be stirred at low temperature until no bubbles were generated. The upper layer of ethyl acetate phase was separated and discarded, and the remaining aqueous phase was adjusted to pH 3 and extracted twice with 1.0L, 500mL of ethyl acetate to remove most of the residual acetic acid. Finally, the pH value of the aqueous solution containing the acetic acid phosphoric acid is adjusted to be neutral by sodium hydroxide for standby, and the enzyme activity test proves that 600ml of 1.1N acetic acid phosphoric acid aqueous solution is obtained.
Example 2: preparation of L-tagatose from galactitol
(1) Preparation of L-tagatose-6-phosphate from galactitol by liquid enzyme (GatDH, TgK)
Figure BDA0003267322640000051
To 1L of 50mM Tris-HCl solution (pH 8.0) was added 27.3 g of galactitol (150mM), 17.6 g of sodium pyruvate (160mM), 2.2 g of adenosine disodium triphosphate ATP (4mM), 1.38 g of nicotinamide adenine dinucleotide monosodium salt (2mM), 165ml of acetic acid phosphate solution (180mM), 2.8 g of magnesium chloride (30mM), 1.5 g of potassium chloride (20mM) in succession; after the pH value is adjusted to 8.0, adding galactitol for dehydrogenationThe reaction is initiated by the enzymes GatDH 2000U, ketohexokinase TgK 4000U, lactate dehydrogenase LDH 1500U and acetate kinase AcK 5000U; during the reaction, acid and alkali are added to maintain the pH value of the system between 7.0 and 8.5, the mixture is slowly stirred at room temperature for 8 hours, then 38.2 g of barium oxalate (150mmol) is added into the reaction solution, and the mixture is mixed with anhydrous ethanol with twice volume after being stirred and dissolved to precipitate L-tagatose-6-phosphoric acid. The white solid was collected by centrifugation and then slowly dissolved in Tris buffer pH 1.0, after which time 21.2 g of anhydrous sodium sulfate (150mmol) was added to remove Ba from the solution2+Ions, and the white precipitate is barium sulfate; then, barium sulfate was removed by filtration, the pH of the supernatant was adjusted to 7.0 with an aqueous NaOH solution, and the mixture was subjected to column chromatography (CRYSTALLINE CHEMICAL) using an anion-exchange resin D201 and eluted with a gradient (0-1N) aqueous ammonia hydrogen carbonate solution to obtain 39 g of a crude L-tagatose-6-phosphate (yield 98%).
(2) Hydrolyzing L-tagatose-6-phosphate with immobilized phosphohydrolase (APase) to obtain L-tagatose
Figure BDA0003267322640000061
26 g of L-tagatose-6-phosphate (100mM) and 77mg of magnesium chloride (2mM) were dissolved in 1L of 25mM Tris.HCl solution, pH 7.0, 2000U of immobilized phosphohydrolase APase was added thereto, and the mixture was slowly stirred at 25 ℃ for 4 hours, followed by direct filtration separation and recovery of the immobilized enzyme. The reaction solution was purified using a D201 anion resin exchange column (pure water as mobile phase), phosphoric acid impurities were adsorbed on the resin and L-tagatose was directly eluted, and finally desalted using a G25 size exclusion column and then suction-dried at low temperature to obtain 13.2G of white foam (yield 73%) as L-tagatose. The immobilized phosphohydrolase (APase) retained 95% of its initial activity after recovery.
HPLC analysis is carried out on the obtained product, and a Phenomenex (Philomena) Rezex RCM series monosaccharide analysis chromatographic column (8mm multiplied by 300mm,9 mu m) is adopted, and the use temperature is 70 ℃; the HPLC chromatogram of the product is shown in FIG. 1, which is obtained by using pure water as the mobile phase at a flow rate of 1ml/min and detecting with a refractive index detector (SHODEX RI-101).
Of the product1The H-NMR spectrum is shown in FIG. 2, Varian 600 meganucleiMagnetic, D2O is a solvent.
From the combination of FIGS. 1 and 2, it can be concluded that the product is L-tagatose.
Example 3: preparation of L-tagatose from D-galactose by liquid enzyme (aldR, GatDH)
Figure BDA0003267322640000062
Adding 18 g of D-galactose (100mM) and 0.71 g of reduced nicotinamide adenine dinucleotide disodium salt (NADH,1mM) into 1L of 50mM Tris-hydrochloric acid (Tris.HCl) solution with pH of 7.5, adjusting the pH value of the solution to 7.5, adding crude enzyme solution (1000U aldR and 3000U GatDH to start the reaction, maintaining the reaction solution at 25 ℃ and slowly stirring for 8 hours, adding acid and alkali to maintain the pH of the reaction system to be 6.5-8.5 during the reaction, adding HCl aqueous solution to adjust the pH to 1.0 after the reaction is finished, terminating the reaction, precipitating protein, filtering to remove, adjusting the reaction solution to pH 7.0, purifying by using D201 anion exchange resin, removing salt from the collected product solution by using a reverse osmosis membrane, concentrating and crystallizing (ethanol: water, 1.5:1, v: v) to obtain 13.5 g of L-tagatose (yield 75%).
HPLC spectrum of the product obtained and1the H-NMR spectra are respectively as shown in FIG. 1 and FIG. 2, and the product is presumed to be L-tagatose.
Example 4: preparation of L-tagatose from D-galactose by immobilized Mixed enzyme (aldR, GatDH)
Similar to example 3, but mixed immobilized aldR, GatDH enzyme was used for catalysis instead of liquid enzyme. The immobilized enzyme can be recycled after the reaction.
Similarly, 18 g of D-galactose (100mM) and 0.71 g of reduced nicotinamide adenine dinucleotide disodium salt (NADH,1mM) were added to 1L of 50mM Tris-hydrochloric acid (Tris.HCl) solution having a pH of 8.0, and after the pH of the solution was adjusted to 8.0, 4000U of immobilized enzyme (aldR: GatDH activity ratio: 1:4) was added to start the reaction, and the reaction solution was slowly stirred at 25 ℃ for 10 hours while maintaining the system pH at 6.5 to 8.5 during the reaction. After the reaction is finished, filtering and recovering the immobilized enzyme (the immobilized enzyme is washed for three times by 50mM of a Tris buffer solution with the pH value of 8.0 and then is stored for standby at 4 ℃), adjusting the pH value of the filtrate to 7.0, purifying by using D201 anion exchange resin, desalting the collected product solution by using a reverse osmosis membrane, concentrating and crystallizing (ethanol: water, 1.5:1, v: v) to obtain 11 g of L-tagatose (the yield is 61%), wherein the immobilized mixed enzyme recovered by filtering has 80% of initial enzyme activity.
HPLC spectrum of the product obtained and1the H-NMR spectra are respectively as shown in FIG. 1 and FIG. 2, and the product is presumed to be L-tagatose.
Example 5: fermentative production of enzymes
The enzyme used in the method is obtained by fermentation production, and the following basic operation flow for preparing the enzyme is as follows:
firstly, synthesizing a gene sequence (SEQ. ID. NO. 1-NO. 6) corresponding to the enzyme by a gene company (Anhui general organisms), then subcloning the gene sequence to pET28a plasmid through NdeI/XhoI enzyme cutting sites, transferring the plasmid into E.coli (BL21) (engine organisms) cells for plate culture, and finally selecting a single clone for liquid step-by-step amplification culture.
Firstly transferring a single colony on a plate into 5ml of LB culture solution (37 ℃) containing 50 mu M kanamycin for culture, inoculating the single colony into 250ml of LB culture solution containing the same antibiotics after the cells grow to a logarithmic phase, and finally transferring the single colony into a 5L culture fermentation tank for culture; when the OD600 of the cells was about 20, 0.5mM isopropyl-. beta. -D-thiogalactopyranoside (IPTG) was added to induce protein expression for 6 hours at 26 ℃ and then centrifuged (4000rpm,15min) to collect 30-55g of wet cells.
To verify the expression of the enzyme, a small amount of cells are taken and uniformly mixed with tris (hydroxymethyl) aminomethane hydrochloride (Tris.HCl) buffer (50mM, pH 8.0), then the cells are crushed by a freeze-thaw method, and after high-speed centrifugation, the supernatant is taken and SDS-PAGE protein gel (sodium dodecyl sulfate-polyacrylamide gel) is run to determine the soluble expression of the protein (figure 3);
and (3) uniformly mixing the residual cells with a buffer solution (10 g of wet cells are mixed with about 200ml of buffer solution on the market), then carrying out high-pressure cell disruption and high-speed centrifugation (16000rpm,45min) to remove cell walls, and finally directly carrying out subsequent use on the obtained enzyme-containing clear liquid (namely the crude enzyme liquid) (the activity of the crude enzyme liquid is 150-350U/ml, U is the enzyme amount required for converting 1 mu mol of substrate at room temperature for one minute) or further purifying and then immobilizing for use (solid enzyme reaction).
The LB medium is composed of: 1% tryptone, 0.5% yeast powder, 1% NaCl, 1% dipotassium hydrogen phosphate and 5% glycerol.
Example 6: immobilization of enzymes
Ammonium sulfate solids were gradually added to the crude enzyme solutions of galactose reductase (aldR), galactitol dehydrogenase (GatDH) and phosphohydrolase (APase) collected above until enzyme precipitation (35% -60%, w/v ammonium sulfate/buffer). The enzyme solid was then collected by centrifugation (10000rpm,12min) and slowly dissolved in 25mM Tris buffer pH 8.0, and finally desalted on a G25 size exclusion column (purchased from Sigma) and separated on a DEAE Seplite FF anion exchange column to give the primary purified liquid enzymes aldR, GatDH, APase.
Primary purified liquid enzymes aldR and GatDH are mixed and fixed at one time by LX-1000EP epoxy resin (Xian blue Xiao Co.) according to a certain activity ratio; the purified enzyme APase was also immobilized singly using LX-1000 EP.
The basic method for fixing is as follows: mixing aldR with GatDH and dissolving in 1L 50mM potassium phosphate solution pH 8.0, adding 40mM phenoxyacetic acid and 300 g LX-1000EP epoxy resin to the buffer solution, stirring at room temperature for 4 hours, filtering out the immobilized enzyme, washing three times with clear water and 25mM phosphate buffer pH 8.0, and drying at low temperature. The immobilized aldR and GatDH mixed enzyme has 70-85% of the activity of the corresponding liquid enzyme.
The immobilization method of the phosphohydrolase (APase) is basically the same as the immobilization method of the mixed enzyme, and the enzyme activity after the immobilization of 2000U of the initially purified APase solution is 85-94% of that of the liquid enzyme.
The immobilization method of galactitol dehydrogenase (GatDH), ketohexokinase (TgK), Lactate Dehydrogenase (LDH), and acetate kinase (AcK) is basically the same as the above-described mixed enzyme immobilization.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Sequence listing
<110> university of south China
Synthesis method of <120> L-tagatose
<160> 12
<170> SIPOSequenceListing 1.0
<210> 1
<211> 254
<212> PRT
<213> Rhodococcus sphaeroides (Rhodobacter sphaeroides)
<220>
<223> GatDH
<400> 1
Met Asp Tyr Arg Thr Val Phe Arg Leu Asp Gly Ala Cys Ala Ala Val
1 5 10 15
Thr Gly Ala Gly Ser Gly Ile Gly Leu Glu Ile Cys Arg Ala Phe Ala
20 25 30
Ala Ser Gly Ala Arg Leu Ile Leu Ile Asp Arg Glu Ala Ala Ala Leu
35 40 45
Asp Arg Ala Ala Gln Glu Leu Gly Ala Ala Val Ala Ala Arg Ile Val
50 55 60
Ala Asp Val Thr Asp Ala Glu Ala Met Thr Ala Ala Ala Ala Glu Ala
65 70 75 80
Glu Ala Val Ala Pro Val Ser Ile Leu Val Asn Ser Ala Gly Ile Ala
85 90 95
Arg Leu His Asp Ala Leu Glu Thr Asp Asp Ala Thr Trp Arg Gln Val
100 105 110
Met Ala Val Asn Val Asp Gly Met Phe Trp Ala Ser Arg Ala Phe Gly
115 120 125
Arg Ala Met Val Ala Arg Gly Ala Gly Ala Ile Val Asn Leu Gly Ser
130 135 140
Met Ser Gly Thr Ile Val Asn Arg Pro Gln Phe Ala Ser Ser Tyr Met
145 150 155 160
Ala Ser Lys Gly Ala Val His Gln Leu Thr Arg Ala Leu Ala Ala Glu
165 170 175
Trp Ala Gly Arg Gly Val Arg Val Asn Ala Leu Ala Pro Gly Tyr Val
180 185 190
Ala Thr Glu Met Thr Leu Lys Met Arg Glu Arg Pro Glu Leu Phe Glu
195 200 205
Thr Trp Leu Asp Met Thr Pro Met Gly Arg Cys Gly Glu Pro Ser Glu
210 215 220
Ile Ala Ala Ala Ala Leu Phe Leu Ala Ser Pro Ala Ala Ser Tyr Val
225 230 235 240
Thr Gly Ala Ile Leu Ala Val Asp Gly Gly Tyr Thr Val Trp
245 250
<210> 2
<211> 337
<212> PRT
<213> Rhizobium radiobacter (Agrobacterium fabrum)
<220>
<223> LDH
<400> 2
Met Arg Ile Val Val Tyr Ser Ala Lys Pro Tyr Asp Arg Gln Phe Leu
1 5 10 15
Asp Glu Ala Ala Arg Pro Gly Thr Asp Leu Gln Tyr Cys Glu Ala Arg
20 25 30
Leu Ser Pro Glu Thr Val Ala Leu Ala Asp Gly Ala Val Ala Ile Cys
35 40 45
Ala Phe Val Asn Asp Asp Leu Ser Arg Pro Val Leu Glu Lys Leu Ala
50 55 60
Gly Met Gly Val Arg Leu Val Ala Leu Arg Cys Ala Gly Phe Asn Gln
65 70 75 80
Val Asp Leu Ala Ala Ala Glu Lys Leu Gly Leu Thr Ile Ala Arg Val
85 90 95
Pro Ala Tyr Ser Pro Tyr Ala Val Ala Glu His Thr Met Ala Leu Ile
100 105 110
Leu Ser Leu Asn Arg Lys Ile His Arg Ala Tyr Asn Arg Val Arg Glu
115 120 125
Gly Asn Phe Ala Leu Asp Gly Leu Leu Gly Phe Asp Leu His Gly Lys
130 135 140
Thr Met Gly Ile Val Gly Thr Gly Lys Ile Gly Ala Ile Phe Ala Arg
145 150 155 160
Ile Ala Ala Gly Phe Gly Cys Arg Leu Ile Gly His Asp Leu His Pro
165 170 175
Asn Pro Asp Cys Glu Ala Leu Gly Met Thr Tyr Gly Thr Arg Glu Glu
180 185 190
Leu Phe Arg Thr Ser Asp Ile Val Ala Leu Met Cys Pro Leu Thr Arg
195 200 205
Glu Thr Arg His Leu Ile Arg Arg Glu Thr Leu Pro Leu Leu Lys Lys
210 215 220
Gly Val Met Leu Ile Asn Thr Ser Arg Gly Ala Ile Ile Asp Thr Pro
225 230 235 240
Ala Ala Ile Thr Gly Leu Lys Asp Gly Thr Ile Gly Ser Leu Gly Ile
245 250 255
Asp Val Tyr Glu Glu Glu Ala Asp Leu Phe Phe Glu Asp Leu Ser Asn
260 265 270
Asp Val Leu Arg Asp Asp Val Phe Ala Arg Leu Leu Thr Phe Pro Asn
275 280 285
Val Leu Val Thr Gly His Gln Gly Phe Phe Thr Gln Glu Ala Leu Lys
290 295 300
Asn Ile Ala Asp Thr Thr Ile Gly Asn Ile Glu Ser Phe Val Asp Thr
305 310 315 320
Gly Lys Ala Leu His Ala Val Ser Thr Glu Gln Leu Ala Gly Ala Val
325 330 335
Ser
<210> 3
<211> 576
<212> PRT
<213> Propionibacterium (Propionibacterium namnense)
<220>
<223> TgK
<400> 3
Met Thr Arg Leu Val Asn Asn Pro Asp Asp Phe Pro Ser Gln Ala Val
1 5 10 15
Ala Gly Leu Val Ser Ala Phe Pro Asn Tyr Val Arg Pro Val Phe Gly
20 25 30
Gly Val Val Arg Ala Ala Arg Thr Asp Arg Lys Val Ala Leu Val Val
35 40 45
Gly Gly Gly Ser Gly His Tyr Pro Ala Phe Ala Gly Trp Val Gly Pro
50 55 60
Gly Phe Ala Asp Gly Ala Val Cys Gly Asn Ile Phe Ser Ser Pro Ser
65 70 75 80
Ala Ser Gln Ala Tyr Ala Val Cys Lys Ala Ala Asp Arg Gly Ala Gly
85 90 95
Val Leu Ile Gly Phe Gly Asn Tyr Ala Gly Asp Val Leu His Phe Gly
100 105 110
Gln Ala Ala Glu Arg Leu Arg Ser Glu Gly Ile Asp Ala Arg Cys Leu
115 120 125
Leu Val Thr Asp Asp Ile Ala Ser Gly Gln Glu His Leu Lys Arg Arg
130 135 140
Gly Ile Ala Gly Asp Leu Pro Val Phe Lys Val Thr Ala Ala Ala Cys
145 150 155 160
Glu Glu Gly Arg Arg Ile Asp Glu Val Val Ala Val Phe Asp Arg Val
165 170 175
Asn Asp Arg Thr Arg Ser Leu Gly Val Ala Phe Ala Gly Cys Thr Leu
180 185 190
Pro Gly Cys Asp Glu Pro Leu Phe Arg Val Glu Ala Thr Gln Met Gly
195 200 205
Val Gly Met Gly Ile His Gly Glu Pro Gly Ile His Asp Glu Ala Leu
210 215 220
Gly Thr Ala Asp Glu Val Ala Ala Met Leu Val Asp Arg Leu Leu Ala
225 230 235 240
Asp Arg Pro Asn Asn Ser Gly Thr Arg Val Val Pro Ile Val Asn Gly
245 250 255
Leu Gly Ser Thr Lys Tyr Glu Glu Leu Phe Val Leu Trp Asn Ser Val
260 265 270
Ser Arg Arg Leu Glu Asp Ala Gly Leu Thr Ile Val Asp Pro Gln Val
275 280 285
Gly Glu Phe Val Thr Ser Leu Asp Met Ala Gly Val Ser Leu Thr Leu
290 295 300
Val Trp Leu Asp Asp Val Ile Glu Pro Leu Trp Leu Ala Ala Cys Asp
305 310 315 320
Thr Pro Ala Phe Arg Arg Gly Thr Val Ala Gln Val Asp Phe Asp Thr
325 330 335
Thr Pro Leu Pro Gln Glu Val Glu Gln Ile Ser Ile Thr Lys Pro Gly
340 345 350
Ser His Val Ser Gln Arg Leu Ala Gly Val Ile Val Gln Ala Leu Glu
355 360 365
Ala Val Ala Thr Arg Leu Ser Glu Arg Ser Gly Glu Leu Gly Arg Leu
370 375 380
Asp Ser Val Ala Gly Asp Gly Asp His Gly Ile Gly Met Thr Arg Gly
385 390 395 400
Ser Gln Ala Ala Leu Ala Glu Ala Arg Arg Val Arg Gly Asp Gly Ala
405 410 415
Gly Ala Ala Thr Thr Leu Ser Ala Ala Gly Leu Ala Trp Ser Glu His
420 425 430
Ala Gly Gly Thr Ser Gly Ala Leu Trp Gly Ala Val Leu Thr Gly Phe
435 440 445
Gly Ala Val Leu Gly Asp Glu Asp Arg Ala Asp Lys Asp Ala Ile Arg
450 455 460
Gln Ala Ala Arg Ala Ala Leu Asp Ala Val Thr Arg Leu Gly Gly Ala
465 470 475 480
Lys Ala Gly Asp Lys Thr Met Val Asp Ala Met Ile Pro Phe Val Thr
485 490 495
Thr Leu Glu Ser Ser Ala Asp Ala Leu Pro Gln Ala Trp Glu Ser Ala
500 505 510
Cys Arg Ala Ala Asp Ala Ala Ala Gln Ala Thr Ser Glu Met Thr Ala
515 520 525
Lys Ile Gly Arg Ala Arg Pro Leu Gly Glu Lys Ser Leu Gly Thr Pro
530 535 540
Asp Pro Gly Ala Met Ser Phe Cys Glu Val Val Val Ala Val Gly Ser
545 550 555 560
Val Leu Ser Thr Ser Ala Ser Ser Asn Gly Gly Leu Arg Ala Gln Arg
565 570 575
<210> 4
<211> 400
<212> PRT
<213> Escherichia coli (E. coli)
<220>
<223> AcK
<400> 4
Met Ser Ser Lys Leu Val Leu Val Leu Asn Cys Gly Ser Ser Ser Leu
1 5 10 15
Lys Phe Ala Ile Ile Asp Ala Val Asn Gly Glu Glu Tyr Leu Ser Gly
20 25 30
Leu Ala Glu Cys Phe His Leu Pro Glu Ala Arg Ile Lys Trp Lys Met
35 40 45
Asp Gly Asn Lys Gln Glu Ala Ala Leu Gly Ala Gly Ala Ala His Ser
50 55 60
Glu Ala Leu Asn Phe Ile Val Asn Thr Ile Leu Ala Gln Lys Pro Glu
65 70 75 80
Leu Ser Ala Gln Leu Thr Ala Ile Gly His Arg Ile Val His Gly Gly
85 90 95
Glu Lys Tyr Thr Ser Ser Val Val Ile Asp Glu Ser Val Ile Gln Gly
100 105 110
Ile Lys Asp Ala Ala Ser Phe Ala Pro Leu His Asn Pro Ala His Leu
115 120 125
Ile Gly Ile Glu Glu Ala Leu Lys Ser Phe Pro Gln Leu Lys Asp Lys
130 135 140
Asn Val Ala Val Phe Asp Thr Ala Phe His Gln Thr Met Pro Glu Glu
145 150 155 160
Ser Tyr Leu Tyr Ala Leu Pro Tyr Asn Leu Tyr Lys Glu His Gly Ile
165 170 175
Arg Arg Tyr Gly Ala His Gly Thr Ser His Phe Tyr Val Thr Gln Glu
180 185 190
Ala Ala Lys Met Leu Asn Lys Pro Val Glu Glu Leu Asn Ile Ile Thr
195 200 205
Cys His Leu Gly Asn Gly Gly Ser Val Ser Ala Ile Arg Asn Gly Lys
210 215 220
Cys Val Asp Thr Ser Met Gly Leu Thr Pro Leu Glu Gly Leu Val Met
225 230 235 240
Gly Thr Arg Ser Gly Asp Ile Asp Pro Ala Ile Ile Phe His Leu His
245 250 255
Asp Thr Leu Gly Met Ser Val Asp Ala Ile Asn Lys Leu Leu Thr Lys
260 265 270
Glu Ser Gly Leu Leu Gly Leu Thr Glu Val Thr Ser Asp Cys Arg Tyr
275 280 285
Val Glu Asp Asn Tyr Ala Thr Lys Glu Asp Ala Lys Arg Ala Met Asp
290 295 300
Val Tyr Cys His Arg Leu Ala Lys Tyr Ile Gly Ala Tyr Thr Ala Leu
305 310 315 320
Met Asp Gly Arg Leu Asp Ala Val Val Phe Thr Gly Gly Ile Gly Glu
325 330 335
Asn Ala Ala Met Val Arg Glu Leu Ser Leu Gly Lys Leu Gly Val Leu
340 345 350
Gly Phe Glu Val Asp His Glu Arg Asn Leu Ala Ala Arg Phe Gly Lys
355 360 365
Ser Gly Phe Ile Asn Lys Glu Gly Thr Arg Pro Ala Val Val Ile Pro
370 375 380
Thr Asn Glu Glu Leu Val Ile Ala Gln Asp Ala Ser Arg Leu Thr Ala
385 390 395 400
<210> 5
<211> 368
<212> PRT
<213> Pseudomonas aeruginosa (Pseudomonas aeruginosa)
<220>
<223> APase
<400> 5
Met Phe Lys Arg Ser Leu Ile Ala Ala Ser Leu Ser Val Ala Ala Leu
1 5 10 15
Val Ser Ala Gln Ala Met Ala Val Thr Gly Gly Gly Ala Ser Leu Pro
20 25 30
Ala Glu Leu Tyr Lys Gly Ser Ala Asp Ser Ile Leu Pro Ala Asn Phe
35 40 45
Ser Tyr Ala Val Thr Gly Ser Gly Thr Gly Lys Asn Ala Phe Leu Thr
50 55 60
Asn Asn Ser Ser Leu Phe Gly Thr Thr Gly Thr Val His Tyr Ala Gly
65 70 75 80
Ser Asp Ser Val Leu Ser Gly Ser Glu Leu Thr Thr Tyr Asn Ser Asn
85 90 95
Tyr Asn Gly Thr Tyr Gly Pro Leu Ile Gln Ile Pro Ser Val Ala Thr
100 105 110
Ser Val Thr Val Pro Tyr Arg Lys Asp Gly Asn Thr Thr Leu Asn Leu
115 120 125
Thr Ser Ala Gln Leu Cys Asp Ala Phe Ser Gly Ala Lys Thr Thr Trp
130 135 140
Gly Gln Leu Leu Gly Thr Thr Asp Ser Thr Pro Ile Arg Ile Val Tyr
145 150 155 160
Arg Thr Gly Ser Ser Gly Thr Thr Glu Leu Phe Thr Arg His Leu Asn
165 170 175
Ser Ile Cys Pro Thr Arg Phe Ala Thr Asn Ser Thr Phe Thr Asn Ala
180 185 190
Arg Leu Pro Ala Gly Gly Thr Leu Pro Ser Asn Trp Val Gly Val Ala
195 200 205
Ala Thr Ser Thr Val Val Ser Thr Val Lys Ala Thr Asn Gly Ser Leu
210 215 220
Gly Tyr Val Ser Pro Asp Ala Val Asn Ile Asn Ser Asn Ala Glu Val
225 230 235 240
Ser Arg Val Asn Gly Asn Leu Pro Thr Gln Ala Asn Val Ser Thr Ala
245 250 255
Leu Gly Ser Val Ala Pro Pro Ala Asn Ala Ala Asp Arg Ala Asp Pro
260 265 270
Ser Lys Trp Val Pro Val Phe Thr Asn Pro Ser Ala Gly Tyr Ser Ile
275 280 285
Val Gly Tyr Thr Asn Phe Val Phe Gly Gln Cys Tyr Lys Asp Ala Ser
290 295 300
Val Ser Thr Asp Val Arg Ala Phe Ile Asn Lys His Tyr Gly Gly Thr
305 310 315 320
Thr Thr Asn Ala Ala Val Ala Ala His Gly Phe Ile Pro Leu Thr Pro
325 330 335
Ala Trp Lys Ser Ala Ile Val Ser Ala Phe Tyr Thr Gly Thr Ser Glu
340 345 350
Asn Leu Ala Ile Gly Asn Thr Asn Val Cys Asn Thr Lys Gly Arg Pro
355 360 365
<210> 6
<211> 290
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> aldR
<400> 6
Met Gly Ala Glu His Ala Val Ala Ser Pro Phe Thr Leu Ala Ser Ser
1 5 10 15
Val Lys Leu Arg Asn Gly Ala Gln Met Pro Arg Leu Gly Phe Gly Val
20 25 30
Phe Gln Ser Thr Asn Ala Lys Ala Ser Thr Ala His Ala Leu Thr Met
35 40 45
Gly Tyr Arg His Ile Asp Ser Ala Arg Tyr Tyr His Asn Glu Glu Glu
50 55 60
Val Cys Ala Ala Val Gln Lys Phe Ser Gly Gly Asn Leu Pro Asn Glu
65 70 75 80
Gly Thr Gly Lys Val Trp Leu Thr Thr Lys Val Met Gly Gln Glu His
85 90 95
Gly Thr Asp Gln Thr Asn Lys Ala Val Asp Glu Ser Val Ala Ile Ala
100 105 110
Lys Lys Tyr Gly Leu Thr Trp Asp Leu Phe Leu Leu His Asp Pro Thr
115 120 125
Ala Gly Lys Gln Lys Arg Leu Glu Ala Trp Lys Val Leu Ile Glu Lys
130 135 140
Arg Asp Gln Gly Leu Ile Lys Ser Ile Gly Val Ser Asn Phe Gly Val
145 150 155 160
Lys His Leu Glu Gln Ile Lys Glu Ala Gly Leu Glu Thr Pro Glu Val
165 170 175
Asn Gln Ile Glu Leu His Pro Phe Leu Gln Gln Arg Asp Ile Val Glu
180 185 190
Tyr Cys Glu Lys Glu Gly Ile Val Val Glu Ala Tyr Cys Pro Ile Leu
195 200 205
Arg Gly Lys Arg Phe Asp Asp Pro Thr Leu Val Glu Leu Ser Lys Lys
210 215 220
His Ser Val Thr Val Pro Gln Ile Leu Ile Arg Trp Ser Leu Gln Lys
225 230 235 240
Gly Phe Val Pro Leu Pro Trp Leu Asp Thr Pro Gly Met Ile Gln Ala
245 250 255
Asn Ala Asp Leu Trp Asp Phe Glu Leu Asp Glu Gly Asp Met Gln Gln
260 265 270
Met Glu Lys Leu Asp Glu Gly Tyr Ala Val Ser Trp Asn Pro Val Asn
275 280 285
Val Glu
290
<210> 7
<211> 765
<212> DNA
<213> Rhodococcus sphaeroides (Rhodobacter sphaeroides)
<220>
<223> GatDH
<400> 7
atggattatc gcaccgtgtt tcgcctggat ggcgcgtgcg cggcggtgac cggcgcgggc 60
agcggcattg gcctggaaat ttgccgcgcg tttgcggcga gcggcgcgcg cctgattctg 120
attgatcgcg aagcggcggc gctggatcgc gcggcgcagg aactgggcgc ggcggtggcg 180
gcgcgcattg tggcggatgt gaccgatgcg gaagcgatga ccgcggcggc ggcggaagcg 240
gaagcggtgg cgccggtgag cattctggtg aacagcgcgg gcattgcgcg cctgcatgat 300
gcgctggaaa ccgatgatgc gacctggcgc caggtgatgg cggtgaacgt ggatggcatg 360
ttttgggcga gccgcgcgtt tggccgcgcg atggtggcgc gcggcgcggg cgcgattgtg 420
aacctgggca gcatgagcgg caccattgtg aaccgcccgc agtttgcgag cagctatatg 480
gcgagcaaag gcgcggtgca tcagctgacc cgcgcgctgg cggcggaatg ggcgggccgc 540
ggcgtgcgcg tgaacgcgct ggcgccgggc tatgtggcga ccgaaatgac cctgaaaatg 600
cgcgaacgcc cggaactgtt tgaaacctgg ctggatatga ccccgatggg ccgctgcggc 660
gaaccgagcg aaattgcggc ggcggcgctg tttctggcga gcccggcggc gagctatgtg 720
accggcgcga ttctggcggt ggatggcggc tataccgtgt ggtga 765
<210> 8
<211> 1014
<212> DNA
<213> Rhizobium radiobacter (Agrobacterium fabrum)
<220>
<223> LDH
<400> 8
atgcgcattg tggtgtatag cgcgaaaccg tatgatcgcc agtttctgga tgaagcggcg 60
cgcccgggca ccgatctgca gtattgcgaa gcgcgcctga gcccggaaac cgtggcgctg 120
gcggatggcg cggtggcgat ttgcgcgttt gtgaacgatg atctgagccg cccggtgctg 180
gaaaaactgg cgggcatggg cgtgcgcctg gtggcgctgc gctgcgcggg ctttaaccag 240
gtggatctgg cggcggcgga aaaactgggc ctgaccattg cgcgcgtgcc ggcgtatagc 300
ccgtatgcgg tggcggaaca taccatggcg ctgattctga gcctgaaccg caaaattcat 360
cgcgcgtata accgcgtgcg cgaaggcaac tttgcgctgg atggcctgct gggctttgat 420
ctgcatggca aaaccatggg cattgtgggc accggcaaaa ttggcgcgat ttttgcgcgc 480
attgcggcgg gctttggctg ccgcctgatt ggccatgatc tgcatccgaa cccggattgc 540
gaagcgctgg gcatgaccta tggcacccgc gaagaactgt ttcgcaccag cgatattgtg 600
gcgctgatgt gcccgctgac ccgcgaaacc cgccatctga ttcgccgcga aaccctgccg 660
ctgctgaaaa aaggcgtgat gctgattaac accagccgcg gcgcgattat tgataccccg 720
gcggcgatta ccggcctgaa agatggcacc attggcagcc tgggcattga tgtgtatgaa 780
gaagaagcgg atctgttttt tgaagatctg agcaacgatg tgctgcgcga tgatgtgttt 840
gcgcgcctgc tgacctttcc gaacgtgctg gtgaccggcc atcagggctt ttttacccag 900
gaagcgctga aaaacattgc ggataccacc attggcaaca ttgaaagctt tgtggatacc 960
ggcaaagcgc tgcatgcggt gagcaccgaa cagctggcgg gcgcggtgag ctaa 1014
<210> 9
<211> 1731
<212> DNA
<213> Propionibacterium (Propionibacterium namnense)
<220>
<223> TgK
<400> 9
atgacccgcc tggtgaacaa cccggatgat tttccgagcc aggcggtggc gggcctggtg 60
agcgcgtttc cgaactatgt gcgcccggtg tttggcggcg tggtgcgcgc ggcgcgcacc 120
gatcgcaaag tggcgctggt ggtgggcggc ggcagcggcc attatccggc gtttgcgggc 180
tgggtgggcc cgggctttgc ggatggcgcg gtgtgcggca acatttttag cagcccgagc 240
gcgagccagg cgtatgcggt gtgcaaagcg gcggatcgcg gcgcgggcgt gctgattggc 300
tttggcaact atgcgggcga tgtgctgcat tttggccagg cggcggaacg cctgcgcagc 360
gaaggcattg atgcgcgctg cctgctggtg accgatgata ttgcgagcgg ccaggaacat 420
ctgaaacgcc gcggcattgc gggcgatctg ccggtgttta aagtgaccgc ggcggcgtgc 480
gaagaaggcc gccgcattga tgaagtggtg gcggtgtttg atcgcgtgaa cgatcgcacc 540
cgcagcctgg gcgtggcgtt tgcgggctgc accctgccgg gctgcgatga accgctgttt 600
cgcgtggaag cgacccagat gggcgtgggc atgggcattc atggcgaacc gggcattcat 660
gatgaagcgc tgggcaccgc ggatgaagtg gcggcgatgc tggtggatcg cctgctggcg 720
gatcgcccga acaacagcgg cacccgcgtg gtgccgattg tgaacggcct gggcagcacc 780
aaatatgaag aactgtttgt gctgtggaac agcgtgagcc gccgcctgga agatgcgggc 840
ctgaccattg tggatccgca ggtgggcgaa tttgtgacca gcctggatat ggcgggcgtg 900
agcctgaccc tggtgtggct ggatgatgtg attgaaccgc tgtggctggc ggcgtgcgat 960
accccggcgt ttcgccgcgg caccgtggcg caggtggatt ttgataccac cccgctgccg 1020
caggaagtgg aacagattag cattaccaaa ccgggcagcc atgtgagcca gcgcctggcg 1080
ggcgtgattg tgcaggcgct ggaagcggtg gcgacccgcc tgagcgaacg cagcggcgaa 1140
ctgggccgcc tggatagcgt ggcgggcgat ggcgatcatg gcattggcat gacccgcggc 1200
agccaggcgg cgctggcgga agcgcgccgc gtgcgcggcg atggcgcggg cgcggcgacc 1260
accctgagcg cggcgggcct ggcgtggagc gaacatgcgg gcggcaccag cggcgcgctg 1320
tggggcgcgg tgctgaccgg ctttggcgcg gtgctgggcg atgaagatcg cgcggataaa 1380
gatgcgattc gccaggcggc gcgcgcggcg ctggatgcgg tgacccgcct gggcggcgcg 1440
aaagcgggcg ataaaaccat ggtggatgcg atgattccgt ttgtgaccac cctggaaagc 1500
agcgcggatg cgctgccgca ggcgtgggaa agcgcgtgcc gcgcggcgga tgcggcggcg 1560
caggcgacca gcgaaatgac cgcgaaaatt ggccgcgcgc gcccgctggg cgaaaaaagc 1620
ctgggcaccc cggatccggg cgcgatgagc ttttgcgaag tggtggtggc ggtgggcagc 1680
gtgctgagca ccagcgcgag cagcaacggc ggcctgcgcg cgcagcgctg a 1731
<210> 10
<211> 1203
<212> DNA
<213> Escherichia coli (E. coli)
<220>
<223> AcK
<400> 10
atgagcagca aactggtgct ggtgctgaac tgcggcagca gcagcctgaa atttgcgatt 60
attgatgcgg tgaacggcga agaatatctg agcggcctgg cggaatgctt tcatctgccg 120
gaagcgcgca ttaaatggaa aatggatggc aacaaacagg aagcggcgct gggcgcgggc 180
gcggcgcata gcgaagcgct gaactttatt gtgaacacca ttctggcgca gaaaccggaa 240
ctgagcgcgc agctgaccgc gattggccat cgcattgtgc atggcggcga aaaatatacc 300
agcagcgtgg tgattgatga aagcgtgatt cagggcatta aagatgcggc gagctttgcg 360
ccgctgcata acccggcgca tctgattggc attgaagaag cgctgaaaag ctttccgcag 420
ctgaaagata aaaacgtggc ggtgtttgat accgcgtttc atcagaccat gccggaagaa 480
agctatctgt atgcgctgcc gtataacctg tataaagaac atggcattcg ccgctatggc 540
gcgcatggca ccagccattt ttatgtgacc caggaagcgg cgaaaatgct gaacaaaccg 600
gtggaagaac tgaacattat tacctgccat ctgggcaacg gcggcagcgt gagcgcgatt 660
cgcaacggca aatgcgtgga taccagcatg ggcctgaccc cgctggaagg cctggtgatg 720
ggcacccgca gcggcgatat tgatccggcg attatttttc atctgcatga taccctgggc 780
atgagcgtgg atgcgattaa caaactgctg accaaagaaa gcggcctgct gggcctgacc 840
gaagtgacca gcgattgccg ctatgtggaa gataactatg cgaccaaaga agatgcgaaa 900
cgcgcgatgg atgtgtattg ccatcgcctg gcgaaatata ttggcgcgta taccgcgctg 960
atggatggcc gcctggatgc ggtggtgttt accggcggca ttggcgaaaa cgcggcgatg 1020
gtgcgcgaac tgagcctggg caaactgggc gtgctgggct ttgaagtgga tcatgaacgc 1080
aacctggcgg cgcgctttgg caaaagcggc tttattaaca aagaaggcac ccgcccggcg 1140
gtggtgattc cgaccaacga agaactggtg attgcgcagg atgcgagccg cctgaccgcg 1200
taa 1203
<210> 11
<211> 1107
<212> DNA
<213> Pseudomonas aeruginosa (Pseudomonas aeruginosa)
<220>
<223> APase
<400> 11
atgtttaaac gcagcctgat tgcggcgagc ctgagcgtgg cggcgctggt gagcgcgcag 60
gcgatggcgg tgaccggcgg cggcgcgagc ctgccggcgg aactgtataa aggcagcgcg 120
gatagcattc tgccggcgaa ctttagctat gcggtgaccg gcagcggcac cggcaaaaac 180
gcgtttctga ccaacaacag cagcctgttt ggcaccaccg gcaccgtgca ttatgcgggc 240
agcgatagcg tgctgagcgg cagcgaactg accacctata acagcaacta taacggcacc 300
tatggcccgc tgattcagat tccgagcgtg gcgaccagcg tgaccgtgcc gtatcgcaaa 360
gatggcaaca ccaccctgaa cctgaccagc gcgcagctgt gcgatgcgtt tagcggcgcg 420
aaaaccacct ggggccagct gctgggcacc accgatagca ccccgattcg cattgtgtat 480
cgcaccggca gcagcggcac caccgaactg tttacccgcc atctgaacag catttgcccg 540
acccgctttg cgaccaacag cacctttacc aacgcgcgcc tgccggcggg cggcaccctg 600
ccgagcaact gggtgggcgt ggcggcgacc agcaccgtgg tgagcaccgt gaaagcgacc 660
aacggcagcc tgggctatgt gagcccggat gcggtgaaca ttaacagcaa cgcggaagtg 720
agccgcgtga acggcaacct gccgacccag gcgaacgtga gcaccgcgct gggcagcgtg 780
gcgccgccgg cgaacgcggc ggatcgcgcg gatccgagca aatgggtgcc ggtgtttacc 840
aacccgagcg cgggctatag cattgtgggc tataccaact ttgtgtttgg ccagtgctat 900
aaagatgcga gcgtgagcac cgatgtgcgc gcgtttatta acaaacatta tggcggcacc 960
accaccaacg cggcggtggc ggcgcatggc tttattccgc tgaccccggc gtggaaaagc 1020
gcgattgtga gcgcgtttta taccggcacc agcgaaaacc tggcgattgg caacaccaac 1080
gtgtgcaaca ccaaaggccg cccgtag 1107
<210> 12
<211> 873
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> aldR
<400> 12
atgggcgcgg aacatgcggt ggcgagcccg tttaccctgg cgagcagcgt gaaactgcgc 60
aacggcgcgc agatgccgcg cctgggcttt ggcgtgtttc agagcaccaa cgcgaaagcg 120
agcaccgcgc atgcgctgac catgggctat cgccatattg atagcgcgcg ctattatcat 180
aacgaagaag aagtgtgcgc ggcggtgcag aaatttagcg gcggcaacct gccgaacgaa 240
ggcaccggca aagtgtggct gaccaccaaa gtgatgggcc aggaacatgg caccgatcag 300
accaacaaag cggtggatga aagcgtggcg attgcgaaaa aatatggcct gacctgggat 360
ctgtttctgc tgcatgatcc gaccgcgggc aaacagaaac gcctggaagc gtggaaagtg 420
ctgattgaaa aacgcgatca gggcctgatt aaaagcattg gcgtgagcaa ctttggcgtg 480
aaacatctgg aacagattaa agaagcgggc ctggaaaccc cggaagtgaa ccagattgaa 540
ctgcatccgt ttctgcagca gcgcgatatt gtggaatatt gcgaaaaaga aggcattgtg 600
gtggaagcgt attgcccgat tctgcgcggc aaacgctttg atgatccgac cctggtggaa 660
ctgagcaaaa aacatagcgt gaccgtgccg cagattctga ttcgctggag cctgcagaaa 720
ggctttgtgc cgctgccgtg gctggatacc ccgggcatga ttcaggcgaa cgcggatctg 780
tgggattttg aactggatga aggcgatatg cagcagatgg aaaaactgga tgaaggctat 840
gcggtgagct ggaacccggt gaacgtggaa tga 873

Claims (10)

  1. A method for synthesizing L-tagatose, characterized by comprising the steps of:
    (1) mixing galactitol, adenosine disodium triphosphate ATP, nicotinamide adenine dinucleotide monosodium salt, magnesium salt and potassium salt, adjusting the pH value of a system to 7.0-8.5, adding galactitol dehydrogenase (GatDH) and ketohexokinase (TgK), reacting at room temperature for 4-10 hours, then adding barium oxalate, stirring for dissolving, adding absolute ethyl alcohol, mixing and precipitating L-tagatose-6-phosphoric acid, and centrifuging to collect white solid precipitate; re-dissolving white solid precipitate to remove Ba2+Ionizing and further purifying to obtain L-tagatose-6-phosphoric acid;
    (2) taking L-tagatose-6-phosphate, adding phosphohydrolase (APase), and reacting at 20-30 ℃ for 2-5 hours to generate the L-tagatose.
  2. 2. The method of synthesis according to claim 1, characterized in that: and (2) simultaneously adding Lactate Dehydrogenase (LDH), acetate kinase (AcK), sodium pyruvate and acetic acid phosphate solution into the step (1).
  3. 3. The method of synthesis according to claim 1, characterized in that: re-dissolving the white solid precipitate in the step (1) to remove Ba2+Dissolving the white solid precipitate in Tris buffer solution with pH value of 1.0, and adding anhydrous sodium sulfate and Ba2+Ion reaction to produce white barium sulfate precipitate, filtering and eliminating.
  4. 4. The method of synthesis according to claim 1, characterized in that: further purification as described in step (1) is to remove Ba2+Adjusting the pH value of the supernatant after ionization to be neutral, loading the supernatant into an anion resin exchange column, and eluting and separating by using an ammonia water solution with gradient concentration to obtain the L-tagatose-6-phosphoric acid.
  5. The synthesis method of the L-tagatose is characterized by comprising the following steps:
    mixing D-galactose and reduced nicotinamide adenine dinucleotide disodium salt (NADH), adjusting the pH value of the solution to 6.5-8.5, adding D-galactose reductase (aldR) and galactitol dehydrogenase (GatDH), and reacting at 20-27 ℃ for 4-10 hours to generate L-tagatose;
    the amino acid sequence of the D-galactose reductase is shown in SEQ ID No. 6.
  6. 6. The synthesis method according to claim 1 or 5, characterized in that: and after the reaction is finished, removing or recovering the enzyme, removing impurities from the reaction solution by anion exchange resin, and then desalting, concentrating and crystallizing to obtain the L-tagatose.
  7. 7. The method of synthesis according to claim 6, characterized in that: the enzyme is liquid enzyme or immobilized enzyme.
  8. 8. The method of synthesis according to claim 7, characterized in that:
    if liquid enzyme is adopted, the pH value of a reaction system is adjusted to be strong acid after reaction, protein is precipitated, and the protein is removed by centrifugation;
    if immobilized enzyme is adopted, the reaction is filtered and recycled.
  9. 9. The synthesis method according to claim 1 or 5, characterized in that: the reactant is added into tris (hydroxymethyl) aminomethane hydrochloric acid (Tris.HCl), hydroxyethyl piperazine ethanesulfoacid (Hepes) buffer solution or 3-morpholine propanesulfonic acid (MOPS) buffer solution for reaction.
  10. 10. The synthesis method according to claim 7 or 8, characterized in that: the immobilized enzyme is prepared by the following steps:
    the desired enzymes were mixed or separately dissolved in 50mM potassium phosphate solution pH 8.0, followed by addition of 40mM phenoxyacetic acid and LX-1000EP epoxy resin to the buffer, stirring at room temperature for 5 hours, filtering off the immobilized enzyme, finally washing three times each with clear water and 25mM phosphate buffer pH 8.0, and then drying at low temperature for use.
CN202111090827.2A 2021-09-17 2021-09-17 Synthetic method of L-tagatose Pending CN113881731A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111090827.2A CN113881731A (en) 2021-09-17 2021-09-17 Synthetic method of L-tagatose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111090827.2A CN113881731A (en) 2021-09-17 2021-09-17 Synthetic method of L-tagatose

Publications (1)

Publication Number Publication Date
CN113881731A true CN113881731A (en) 2022-01-04

Family

ID=79009521

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111090827.2A Pending CN113881731A (en) 2021-09-17 2021-09-17 Synthetic method of L-tagatose

Country Status (1)

Country Link
CN (1) CN113881731A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018182344A1 (en) * 2017-03-31 2018-10-04 씨제이제일제당(주) Composition for tagatose production and method for tagatose production using same
CN110452942A (en) * 2019-08-23 2019-11-15 华南师范大学 Immobilized enzyme catalysis method prepares D- ribulose
CN113337484A (en) * 2021-06-03 2021-09-03 江苏大学 Double-enzyme catalytic system for preparing L-tagatose and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018182344A1 (en) * 2017-03-31 2018-10-04 씨제이제일제당(주) Composition for tagatose production and method for tagatose production using same
CN110452942A (en) * 2019-08-23 2019-11-15 华南师范大学 Immobilized enzyme catalysis method prepares D- ribulose
CN113337484A (en) * 2021-06-03 2021-09-03 江苏大学 Double-enzyme catalytic system for preparing L-tagatose and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GENBANK: "PRQ69900.1", 《GENBANK》 *
徐铮等: "生物法生产D-塔格糖的研究进展", 《生物加工过程》 *
王淑如主编: "《生物化学》", 31 July 1994, 中国医药科技出版社 *

Similar Documents

Publication Publication Date Title
CA2653028C (en) Method for the enzymatic production of 2-hydroxy-2-methyl carboxylic acids
CN108690854B (en) Method for producing L-glufosinate-ammonium by using chemical-enzymatic method
AU2008249370B2 (en) Method for producing glucuronic acid by glucuronic acid fermentation
CN114507681A (en) Sorbose reductase OpCR gene, mutant and encoded protein and application in preparation of vitronectin
WO1997008332A1 (en) A process for production of citric acid and monovalent citrate salts
JP4012596B2 (en) L-ribose isomerase, production method and use thereof
CN114540380A (en) Sorbitol dehydrogenase sorDHGo gene, encoding protein and application in preparation of vitreous chromogen
CN115927216A (en) Preparation method of S-nicotine
CN113881731A (en) Synthetic method of L-tagatose
US8227232B2 (en) Thermostable L-ribose isomerase and method for producing same and use of same
JPH08154696A (en) Production of l-ketohexose
CN113881730B (en) Method for synthesizing L-galactose
CN114875087B (en) Method for synthesizing 5-hydroxy beta-indolylalanine by taking beta-indolylalanine as substrate and application thereof
CN112941045A (en) Recombinant transaminase and method for synthesizing L-phenylglycinol
JP4011496B2 (en) Method for producing L-glucose
JP4571961B2 (en) L-ribose isomerase, production method and use thereof
KR100345847B1 (en) Process for preparing cefazolin by using immobilized enzyme
CN113881728A (en) Preparation method of 7-aminomethyl-7-deazaguanine (PreQ1)
JPS6225353B2 (en)
JPS615793A (en) Production of d-aspartic acid
JPS58878B2 (en) L (+) - Shiyusekisanno Seizouhou
JP2001017193A (en) Production of monohydroxyadamantane esters
JP2004000082A (en) Process for preparing d-tagatose
JPH10324693A (en) Purification of fructose-2,6-bisphosphate
JP2001017194A (en) Production of monohydroxyadamantane derivative

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20220104

RJ01 Rejection of invention patent application after publication